SpaceX Stock Enters a New Orbit: Analyst Coverage and Index Inclusion Create a Volatile Cocktail

The quiet period that followed SpaceX’s $85.7 billion IPO ends today, unleashing a torrent of analyst reports from the underwriting syndicate—Goldman Sachs, JPMorgan, and Citigroup. The market’s silence has already been broken by independent researchers, with 13 analysts covering the stock and setting an average price target of roughly $229, implying a 45% upside from current levels. Andrew Beale of Arete Research stands out as the most bullish, issuing a $401 target.

Yet the arrival of institutional coverage coincides with an environment of extreme turbulence. SpaceX officially entered the Nasdaq-100 last week, and the options market is flashing warning signals. Implied volatility stands at 92—nearly three-and-a-half times that of the QQQ tech ETF, itself no stranger to swings. Almost half a million SpaceX options traded by Monday midday, with calls outpacing puts by more than two to one. Cboe vice president JJ Kinahan cautioned investors to brace for $20 intraday moves over the next week and a half, noting that options volume is running two-and-a-half times normal levels.

The index inclusion, while a milestone, has not delivered the automatic price boost many hoped for. With only 4% of SpaceX shares in the public float, the passive fund buying is expected to be modest. JPMorgan estimates the stock will carry a 1.3% weight in the Nasdaq-100, placing it at number 21. Analysts at Arete Research warn that the thin float cuts both ways: ETF demand provides a short-term cushion, but a correction could expose fragile liquidity. “The index effect is less meaningful than expected because the mechanism was already priced in,” said Paul Meeks of Freedom Capital Markets.

Short sellers are already heading for the exits. The Leverage Shares 2X Short SpaceX Daily ETF has shrunk from a peak of over $166 million to roughly $93 million, while a similar product from GraniteShares has also bled capital. The stock currently trades about 20% above its IPO price, forcing bearish funds to cover their positions.

Should investors sell immediately? Or is it worth buying SpaceX?

Lockup agreements are beginning to expire in tranches, adding another layer of uncertainty. The first insider shares will become free to trade between 70 and 135 days after the IPO. Elon Musk and other major holders must wait the full 366 days. “These upcoming insider sales represent a clear near-term headwind,” said Susquehanna analyst Charles Minervino. The confluence of passive buying and fresh supply guarantees a volatile autumn.

Competition in the satellite internet space is also heating up. Amazon recently launched 29 satellites for its Project Leo network and aims to offer commercial service later this year, with a first-generation constellation of roughly 3,200 satellites targeted for mid-2029. SpaceX’s Starlink, by contrast, already has over 10,000 satellites in orbit and serves 12 million active users. Still, investors are keeping a close eye on the threat.

The next major catalysts arrive in early August, when SpaceX reports its first quarterly earnings as a public company and the initial lockup tranche matures. Analysts will then measure progress against Elon Musk’s ambitious goal of generating $1 trillion in annual revenue by 2030—a target that the upcoming flood of research reports will scrutinize in detail.